CLEC6A and type 2 diabetes mellitus: Taking into consideration our previous observation regarding the loss of SOCS3 and the activation of Dectin-2 and downstream STAT signaling, we questioned how PBMCs isolated from T2D patients would differ from non-diabetic PBMCs in their response to Dectin-2 stimulation.